Mindray hitting bumps in the road, as analyst warns on margins and US biz
This article was originally published in Clinica
Executive Summary
Mindray Medical International is facing several challenges including weak margins and a "less than stellar" US business, which has prompted one analyst to downgrade the Chinese company – one of the few that have successfully established a solid international presence – from "buy" to "hold".